Christopher Henney -- who co-founded three of Seattle’s biggest biotech companies, Immunex, Icos Corp. and Dendreon -- is now tossing his weight behind a new startup company called CG Therapeutics.Henney was named chairman of the board, with the role of helping the startup with venture funding and corporate partnerships, the company announced Thursday.
